Preventing gastric cancer with antibiotics
March 11, 2010 by admin · Leave a Comment
Contact: Steve Pogonowski
press@f1000.com
44-207-631-9134
Faculty of 1000: Biology and Medicine
Helicobacter pylori, a bacterium found in about 50% of humans worldwide, can cause stomach ulcers and, in extreme cases, gastric cancer. In an article for F1000 Medicine Reports, Seiji Shiota and Yoshio Yamaoka discuss the possible eradication of H. pylori infections
Therapeutic effect of worm-derived proteins on experimental colitis
March 3, 2010 by admin · Leave a Comment
Contact: Jin-Lei Wang
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence of IBD in the Western world. Epidemiological, experimental and clinical data support the idea that worm infection provides protection against IBD. However, treatment of patients with living worms may have serious drawbacks such as infection and/or invasion of the parasite to other tissues. Therefore, therapy with worm-derived proteins might provide a more acceptable form of treatment.
Bowel disease link to blood clots
February 9, 2010 by admin · Leave a Comment
Contact: Emma Rayner
emma.rayner@nottingham.ac.uk
44-011-595-15793
University of Nottingham
People living with Inflammatory Bowel Disease (IBD) are known to be at high risk of blood clots when admitted to hospital during a flare-up of their disease but now new research by scientists at The University of Nottingham has shown that those who are not admitted to hospital during flare-ups are also at risk.
Promising probiotic treatment for inflammatory bowel disease
Contact: Laura Udakis
l.udakis@sgm.ac.uk
44-118-988-1843
Society for General Microbiology
Bacteria that produce compounds to reduce inflammation and strengthen host defences could be used to treat inflammatory bowel disease (IBD). Such probiotic microbes could be the most successful treatment for IBD to date, as explained in a review published in the February issue of the Journal of Medical Microbiology.
Enzyme necessary for development of healthy immune system
December 20, 2009 by admin · Leave a Comment
Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Mice without the deoxycytidine kinase (dCK) enzyme have defects in their adaptive immune system, producing very low levels of both T and B lymphocytes, the major players involved in immune response, according to a study by researchers with UCLA’s Jonsson Comprehensive Cancer Center.
Breakthrough on causes of inflammatory bowel disease
December 15, 2009 by admin · Leave a Comment
Contact: Dr Nicola Eastaff-Leung
nicola.eastaff-leung@adelaide.edu.au
61-881-616-363
University of Adelaide
New research by the University of Adelaide could help explain why some people are more prone to Crohn’s disease, ulcerative colitis and other autoimmune diseases.
Cause of common chronic diarrhea revealed in new research
November 2, 2009 by admin · Leave a Comment
A common type of chronic diarrhoea may be caused by a hormone deficiency, according to new research published in the November issue of Clinical Gastroenterology and Hepatology. The authors of the paper, from Imperial College London, with collaborators from King’s College London and the University of Edinburgh, say their results could help more doctors recognise this type of diarrhoeal illness, and may lead to the development of more effective tests and treatments to help improve the lives of many people suffering with chronic diarrhoea.
Surgeons at Boston Medical Center offering new procedure for acid reflux/GERD
October 26, 2009 by admin · Leave a Comment
Boston Medical Center (BMC) surgeons are now offering patients an incisionless alternative to laparoscopic and traditional surgery for treatment of acid reflux or GERD.
Using the new procedure known as EsophyX TIF (Transoral Incisionless Fundaplication), surgeons can repair or reconstruct the valve between the esophagus and stomach, effectively stopping GERD. BMC is the only hospital in New England offering this new treatment.
Probiotic Found to Be Effective Treatment for Colitis In Mice
October 26, 2009 by admin · Leave a Comment
Bacteria promote new blood vessel growth in intestinal cells
BETHESDA, Md. (Oct. 26, 2009) The probiotic, Bacillus polyfermenticus, can help mice recover from colitis, a new study has found. Mice treated with B. polyfermenticus during the non-inflammatory period of the disease had reduced rectal bleeding, their tissues were less inflamed and they gained more weight than mice that did not receive the treatment.
The bowels of infection
October 21, 2009 by admin · Leave a Comment
Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, “Latent cytomegalovirus infection exacerbates experimental colitis,” appears in the November 2009 issue of The American Journal of Pathology.
